Falta Michael T, Fontenot Andrew P, Rosloniec Edward F, Crawford Frances, Roark Christina L, Bill Jerome, Marrack Philippa, Kappler John, Kotzin Brian L
University of Colorado Health Sciences Center, and National Jewish Medical and Research Center, Denver, Colorado 80262, USA.
Arthritis Rheum. 2005 Jun;52(6):1885-96. doi: 10.1002/art.21098.
Although studies have suggested that human cartilage (HC) gp-39 may be an antigen recognized by autoreactive CD4(+) T cells in rheumatoid arthritis, we previously failed to identify specific CD4(+) T cells in patients' synovial fluid or blood using a class II major histocompatibility complex-peptide tetramer composed of the immunodominant HC gp-39(263-275) epitope covalently linked to DR4. We undertook this study to better understand the parameters for specific binding of this tetramer.
DR4-transgenic mice were immunized with the HC gp-39 peptide, and a set of peptide-responsive hybridomas was derived. Hybridomas were stained with the DR4-gp-39 tetramer and cultured with increasing amounts of peptide in the presence of DR4-expressing antigen-presenting cells to determine functional avidity.
Great variability was apparent in the ability of the tetramer to stain the hybridomas, and there was a strong correlation between the intensity of tetramer staining and functional avidity. Importantly, nearly 30% of the hybridomas did not stain with tetramer, and these cells exhibited relatively low functional avidity. Although the addition of an anti-T cell receptor (anti-TCR) monoclonal antibody during the staining procedure enhanced binding of the tetramer to a number of the hybridomas, a significant percentage remained unstainable. Analysis of TCR expression showed that >90% of the hybridomas expressed the same TCR beta-chain variable region (V(beta)10), and sequencing of the TCR junctional regions showed diversity in the third complementarity-determining region.
These results suggest that immune responses dominated by relatively low-affinity TCR interactions, such as those that may occur in autoimmune disease, will be difficult to detect using standard tetramer techniques.
尽管研究表明人类软骨(HC)gp-39可能是类风湿关节炎中自身反应性CD4(+) T细胞识别的一种抗原,但我们之前未能使用由与DR4共价连接的免疫显性HC gp-39(263 - 275)表位组成的II类主要组织相容性复合体 - 肽四聚体,在患者的滑液或血液中鉴定出特异性CD4(+) T细胞。我们开展这项研究以更好地理解该四聚体特异性结合的参数。
用HC gp-39肽免疫DR4转基因小鼠,并获得一组肽反应性杂交瘤。用DR4-gp-39四聚体对杂交瘤进行染色,并在表达DR4的抗原呈递细胞存在的情况下,用增加量的肽进行培养以确定功能亲和力。
四聚体对杂交瘤染色的能力存在明显差异,并且四聚体染色强度与功能亲和力之间存在强相关性。重要的是,近30%的杂交瘤未被四聚体染色,并且这些细胞表现出相对较低的功能亲和力。尽管在染色过程中添加抗T细胞受体(抗TCR)单克隆抗体增强了四聚体与许多杂交瘤的结合,但仍有相当比例的杂交瘤无法被染色。TCR表达分析表明,>90%的杂交瘤表达相同的TCRβ链可变区(Vβ10),并且TCR连接区测序显示在第三个互补决定区存在多样性。
这些结果表明,由相对低亲和力的TCR相互作用主导的免疫反应,例如可能发生在自身免疫性疾病中的那些反应,使用标准的四聚体技术将难以检测。